- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Ainos, Inc.: Ainos, MacKay Memorial Hospital and Topco Scientific Partner to Advance Smell AI Deployment in High-Risk Hospital Environments | 292 | ACCESS Newswire | Expands AI Nose platform from industrial safety into clinical infrastructure HOUSTON, TX / ACCESS Newswire / April 8, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) today announced a partnership with... ► Artikel lesen | |
| 01.04. | Ainos, Inc.: VASRO Research Highlights Ainos' Smell AI Commercial Progress and 2026 Deployment Momentum | 184 | ACCESS Newswire | Report highlights transition to deployment-driven growth, with visible semiconductor rollout and early customer-backed revenueSmell AI, powered by AI Nose, is emerging as a new AI perception layer,... ► Artikel lesen | |
| 30.03. | Ainos, Inc. WT EXP 072927 reports FY results | 1 | Seeking Alpha | ||
| 30.03. | Ainos, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 30.03. | Ainos, Inc.: Ainos Reports Full Year 2025 Financial Results and Highlights Commercial Momentum Entering 2026 | 173 | ACCESS Newswire | AI Nose drove 499% revenue growth in 2025, with gross margin turning positive to 82.9%2025 partnerships now driving scaled AI Nose deployments in 2026, supported by disciplined financing HOUSTON, TX... ► Artikel lesen | |
| AINOS Aktie jetzt für 0€ handeln | |||||
| 19.03. | Ainos, Inc.: The Wall Street Journal Highlights Emerging "Smell AI" - Ainos Advances Commercial Deployment in Semiconductor Environments | 312 | ACCESS Newswire | As AI expands beyond vision and language, Ainos advances commercial deployment of AI Nose in industrial environments-positioning the Company at the forefront of this emerging category HOUSTON, TX /... ► Artikel lesen | |
| 12.03. | Ainos, Inc.: Water Tower Research Highlights Ainos' Scaling Momentum Across Semiconductor Value Chain | 484 | ACCESS Newswire | AI Nose deployment into front-end wafer fabrication facilities marks a critical validation step in semiconductor manufacturing environmentsRecurring revenue visibility strengthens as AI Nose deployments... ► Artikel lesen | |
| 09.03. | Ainos, Inc.: Ainos Expands AI Nose Validation in Front-End Wafer Fabs with 200 Targeted Deployments in Q1 2026 | 339 | ACCESS Newswire | Company affirms execution milestones, subscription activation roadmap, and long-term infrastructure vision remain unchanged despite market volatility HOUSTON, TEXAS / ACCESS Newswire / March 9, 2026... ► Artikel lesen | |
| 02.03. | Ainos secures initial order for 1,400 AI scent detection systems | 2 | Investing.com | ||
| 02.03. | Ainos, Inc.: Ainos Issues Shareholder Letter on Phased AI Nose Deployment of Up to 20,000 Systems and Scalable Recurring Revenue Opportunity | 1.361 | ACCESS Newswire | HOUSTON, TEXAS / ACCESS Newswire / March 2, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today issued the following letter from Chairman, President and Chief Executive Officer... ► Artikel lesen | |
| 24.02. | Ainos Update - Ainos and ASE: Deposit Received; Phase-One Delivery Targeted (Q2 2026) | 172 | VASRO GmbH | This update is about execution credibility-moving from "roadmap language" to hard markers that can be tracked. In VASRO's initiating coverage, ASE was framed as the industrial anchor customer for AI... ► Artikel lesen | |
| 23.02. | Ainos, Inc.: Ainos Activates Industrial-Scale Deployment Roadmap of Up to 20,000 Units, Advancing AI Infrastructure Integration in Semiconductor Production Environments | 299 | ACCESS Newswire | HOUSTON, TEXAS / ACCESS Newswire / February 23, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced the activation of a phased industrial deployment roadmap under... ► Artikel lesen | |
| 18.02. | Ainos Update - What We Learn from the VELDONA FCGS Interim Readout | 160 | VASRO GmbH | This update is a clinical signal calibration note. Ainos reported interim results from an ongoing open-label, multi-dose study of VELDONA (low-dose oral interferon alpha) in Feline Chronic Gingivostomatitis... ► Artikel lesen | |
| 17.02. | Ainos, Inc.: Ainos Reports Statistically Significant Interim Efficacy Results from VELDONA Clinical Trial in Feline Chronic Gingivostomatitis | 233 | ACCESS Newswire | Open-Label Study Demonstrates Durable Reduction in Oral Inflammation with Favorable Tolerability Profile at Interim Analysis HOUSTON, TEXAS / ACCESS Newswire / February 17, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW)... ► Artikel lesen | |
| 09.02. | Ainos, Inc.: Ainos Initiates Live AI Nose Deployments within Semiconductor Manufacturing Environments | 429 | ACCESS Newswire | Back-end semiconductor deployments begin under initial customer orderFront-end semiconductor pilots advance across targeted environments HOUSTON, TEXAS / ACCESS Newswire / February 9, 2026 / Ainos,... ► Artikel lesen | |
| 05.02. | Ainos, Inc.: Water Tower Research Highlights Mirle Partnership Fueling Ainos' Robotics Scale-Up and SmellTech Expansion | 395 | ACCESS Newswire | AI Nose integration positions robotics application as a scalable growth engineMirle partnership expands SmellTech robotics into industrial environments HOUSTON, TEXAS / ACCESS Newswire / February 5... ► Artikel lesen | |
| 04.02. | Ainos, Inc.: Water Tower Research Fireside Chat with Ainos: AI Nose Powering SmellTech Expansion and Scalable Value Creation | 440 | ACCESS Newswire | AI Nose advances through a dual-engine architecture, enabling scalable deploymentsIndustrial and semiconductor deployments broaden Ainos' commercial footprintRobotics momentum accelerates data flywheel... ► Artikel lesen | |
| 03.02. | Ainos Update - AI Nose Expands into Robotic Sensing for Inspection & Safety Monitoring (Mirle Automation Partnership) | 162 | VASRO GmbH | This update isolates a specific operational development: Ainos announced a technology partnership with Mirle Automation Corporation to integrate AI Nose into mobile and quadruped robotic platforms,... ► Artikel lesen | |
| 02.02. | Ainos, Inc.: Ainos and Mirle Automation Partner to Bring Scent Intelligence to Robots and Quadruped Robots | 576 | ACCESS Newswire | AI Nose introduces scent as a machine-readable signal for robotic perceptionPartnership targets real-world deployment in mobile and quadruped robotic platforms HOUSTON, TEXAS / ACCESS Newswire / February... ► Artikel lesen | |
| 28.01. | Morning Market Movers: Murano Global Investments, Flora Growth, Kustom Entertainment, Ainos See Big Swings | 752 | AFX News | OTTAWA (dpa-AFX) - At 7:20 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen |
1 2 3 4 Weiter >>
77 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EVOTEC | 4,526 | -3,21 % | Evotec-Aktie: Neuzugang könnte neue Hoffnungen wecken | Die Evotec-Aktie blieb in der schwachen Phase der Börsen stabil und konnte sich entgegen dem Trend leicht erholen. Am Donnerstag ging sie mit einem Gewinn von +2,2% aus dem Handel und steht bei rund... ► Artikel lesen | |
| BB BIOTECH | 48,300 | +0,21 % | Dividenden als Portfolio-Anker: Alte Bekannte Sanofi und BB Biotech - Geheimtipp RE Royalties | In einem Marktumfeld, das von strukturellen Umbrüchen geprägt ist, rückt die Stabilität des Portfolios in den Fokus. Analysten von J.P. Morgan betonen, dass der Schutz von Buchgewinnen der vergangenen... ► Artikel lesen | |
| MEDIGENE | 0,026 | -17,20 % | Medigene: Zurückziehung - 18.11.2025 | ||
| QIAGEN | 35,030 | -1,14 % | QIAGEN N.V.: Qiagen Announces Form 20-F Annual Report Filing for 2025 Results | QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has filed its annual report, including its audited consolidated financial statements on Form 20-F, for the year ended... ► Artikel lesen | |
| PAION | 0,051 | -19,20 % | XFRA MISTRADE ANTRAG IN ISIN DE000A3E5EG5 WURDE STATTGEGEBEN | Dem Mistrade-Antrag wurde stattgegeben. Folgende Geschaefte in der ISIN DE000A3E5EG5, Wertpapier-Name: PAION AG INH O.N., wurden aufgehoben:ISIN Datum Zeit Volumen PreisDE000A3E5EG5 02.02.2026 08:13:40 300 0... ► Artikel lesen | |
| VALNEVA | 2,640 | +1,30 % | Valneva unter massivem Druck: Warum Insider bereits still und leise verkaufen - Was Sie jetzt noch wissen müssen | ||
| AMGEN | 303,85 | 0,00 % | Amgen: Phase 3 Trial Of TEPEZZA Meets Primary And Key Secondary Endpoints | THOUSAND OAKS (dpa-AFX) - Amgen (AMGN) announced positive topline results from a Phase 3 trial of TEPEZZA administered by subcutaneous injection via an on-body injector in participants with... ► Artikel lesen | |
| EPIGENOMICS | 0,870 | 0,00 % | PTA-AFR: Epigenomics AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114-117 WpHG | DJ PTA-AFR: Epigenomics AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114-117 WpHG
Vorabbekanntmachung Finanzberichte gemäß ---- 114-117 WpHG
Epigenomics... ► Artikel lesen | |
| NOVAVAX | 7,330 | +0,55 % | Activist investor revives campaign to overhaul Novavax board | ||
| STRYKER | 289,50 | -0,10 % | Outset Medical adds former Stryker leader as new EVP of commercial | ||
| BIOGEN | 150,00 | -0,87 % | Weekly Buzz: ARS Pharmaceuticals Gains FDA Nod; Novo Nordisk received FDA approval for Awiqli; EU Expands Kerendia Label; Eli Lilly Acquires Centessa Pharmaceuticals; Biogen Snaps Up Apellis Pharmaceuticals | BASEL (dpa-AFX) - This week's biotech landscape witnessed regulatory approvals across the U.S., EU, and China, acquisitions, a few key trial goal misses and positive clinical trial data readouts... ► Artikel lesen | |
| BIOFRONTERA | 2,610 | +1,95 % | BIOFRONTERA AG im Abwärtsmodus - ruhige Einordnung | ||
| HEIDELBERG PHARMA | 2,760 | -1,08 % | EQS-News: Heidelberg Pharma AG: Heidelberg Pharma präsentiert Ergebnisse ihrer proprietären ADC-Technologieplattform auf der AACR-Jahrestagung 2026 | EQS-News: Heidelberg Pharma AG
/ Schlagwort(e): Wissenschaftl. Publikation
Heidelberg Pharma präsentiert Ergebnisse ihrer proprietären ADC-Technologieplattform auf der AACR-Jahrestagung... ► Artikel lesen | |
| ILLUMINA | 105,52 | -0,13 % | Illumina Expands Collaboration With Labcorp To Advance Precision Oncology | SAN DIEGO (dpa-AFX) - Illumina, Inc. (ILMN), Wednesday announced an expanded collaboration with Labcorp to advance precision oncology through innovative applications of next-generation sequencing... ► Artikel lesen | |
| CRISPR THERAPEUTICS | 44,575 | +0,80 % | Quant ratings on Cathie Wood's top holdings: TSLA, CRSP, AMD, and TEM |
AINOS INC gehört der Branche Biotechnologie an. Die relative Kursveränderung beträgt aktuell -3,49 % bei einem Aktienkurs von 1,660 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu AINOS INC finden Sie auf Wallstreet Online.